Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Chapman

Showing results (171-180 of 320) with videos related to

Pageof 32
Sort By:
Journal of Lipid Research|September 2, 2016
Statin action enriches HDL3 in polyunsaturated phospholipids and plasmalogens and reduces LDL-derived phospholipid hydroperoxides in atherogenic mixed dyslipidemiaAlexina Orsoni, Patrice Thérond, Ricardo Tan, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 28, 2009
Proteomic analysis of defined HDL subpopulations reveals particle-specific protein clusters: relevance to antioxidative functionW Sean Davidson, R A Gangani D Silva, Sandrine Chantepie, et al.
Vascular Pharmacology|June 18, 2019
Cost effectiveness of lifelong therapy with PCSK9 inhibitors for lowering cardiovascular events in patients with stable coronary artery disease: Insights from the Ludwigshafen Risk and Cardiovascular Health cohortAlexander Dressel, Burkhard Schmidt, Nina Schmidt, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 24, 2007
Inhibition of CETP by torcetrapib attenuates the atherogenicity of postprandial TG-rich lipoproteins in type IIB hyperlipidemiaMaryse Guerin, Wilfried Le Goff, Emilie Duchene, et al.
Journal of Clinical Lipidology|August 23, 2017
Paradoxical coronary artery disease in humans with hyperalphalipoproteinemia is associated with distinct differences in the high-density lipoprotein phosphosphingolipidomeWilliam Hancock-Cerutti, Marie Lhomme, Carolane Dauteuille, et al.
The Journal of Clinical Endocrinology and Metabolism|February 4, 2011
Effect of bariatric surgery-induced weight loss on SR-BI-, ABCG1-, and ABCA1-mediated cellular cholesterol efflux in obese womenJudith Aron-Wisnewsky, Zélie Julia, Christine Poitou, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 21, 2007
Enhanced immune system activation and arterial inflammation accelerates atherosclerosis in lupus-prone miceEmmanuel L Gautier, Thierry Huby, Betty Ouzilleau, et al.
The Journal of Clinical Investigation|September 12, 2006
Knockdown expression and hepatic deficiency reveal an atheroprotective role for SR-BI in liver and peripheral tissuesThierry Huby, Chantal Doucet, Christiane Dachet, et al.
European Heart Journal Supplements : Journal of the European Society of Cardiology|October 16, 2020
Beyond cardiovascular medicine: potential future uses of icosapent ethylDeepak L Bhatt, Mark A Hull, Mingyang Song, et al.
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids|May 23, 2017
Structure-function relationships in reconstituted HDL: Focus on antioxidative activity and cholesterol efflux capacityAlexandre M O Cukier, Patrice Therond, Svetlana A Didichenko, et al.
Pageof 32

Showing results (171-180 of 320) with videos related to

Sort By:
Pageof 32
Journal of Lipid Research|September 2, 2016
Statin action enriches HDL3 in polyunsaturated phospholipids and plasmalogens and reduces LDL-derived phospholipid hydroperoxides in atherogenic mixed dyslipidemiaAlexina Orsoni, Patrice Thérond, Ricardo Tan, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 28, 2009
Proteomic analysis of defined HDL subpopulations reveals particle-specific protein clusters: relevance to antioxidative functionW Sean Davidson, R A Gangani D Silva, Sandrine Chantepie, et al.
Vascular Pharmacology|June 18, 2019
Cost effectiveness of lifelong therapy with PCSK9 inhibitors for lowering cardiovascular events in patients with stable coronary artery disease: Insights from the Ludwigshafen Risk and Cardiovascular Health cohortAlexander Dressel, Burkhard Schmidt, Nina Schmidt, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 24, 2007
Inhibition of CETP by torcetrapib attenuates the atherogenicity of postprandial TG-rich lipoproteins in type IIB hyperlipidemiaMaryse Guerin, Wilfried Le Goff, Emilie Duchene, et al.
Journal of Clinical Lipidology|August 23, 2017
Paradoxical coronary artery disease in humans with hyperalphalipoproteinemia is associated with distinct differences in the high-density lipoprotein phosphosphingolipidomeWilliam Hancock-Cerutti, Marie Lhomme, Carolane Dauteuille, et al.
The Journal of Clinical Endocrinology and Metabolism|February 4, 2011
Effect of bariatric surgery-induced weight loss on SR-BI-, ABCG1-, and ABCA1-mediated cellular cholesterol efflux in obese womenJudith Aron-Wisnewsky, Zélie Julia, Christine Poitou, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 21, 2007
Enhanced immune system activation and arterial inflammation accelerates atherosclerosis in lupus-prone miceEmmanuel L Gautier, Thierry Huby, Betty Ouzilleau, et al.
The Journal of Clinical Investigation|September 12, 2006
Knockdown expression and hepatic deficiency reveal an atheroprotective role for SR-BI in liver and peripheral tissuesThierry Huby, Chantal Doucet, Christiane Dachet, et al.
European Heart Journal Supplements : Journal of the European Society of Cardiology|October 16, 2020
Beyond cardiovascular medicine: potential future uses of icosapent ethylDeepak L Bhatt, Mark A Hull, Mingyang Song, et al.
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids|May 23, 2017
Structure-function relationships in reconstituted HDL: Focus on antioxidative activity and cholesterol efflux capacityAlexandre M O Cukier, Patrice Therond, Svetlana A Didichenko, et al.
Pageof 32